FIELD: medicine.
SUBSTANCE: liquid preparation forms of improved light resistance contain aqueous Sitafloxacin and sodium chloride solution.
EFFECT: wide range of functional applications.
22 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID PREPARATION OF HIGH ABSORPTION | 2001 |
|
RU2287328C2 |
| DERIVATIVES OF QUINOLONE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1998 |
|
RU2193558C2 |
| COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
| REDUCED DOSAGE OF ANTIBIOTIC IN ANTIBIOTIC/ANTI-INFLAMMATORY AGENT COMPOSITIONS COMBINED FOR OPHTHALMIC USE | 2020 |
|
RU2820235C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2435583C1 |
| TRI- OR TETPA-SUBSTITUTED-3-AMINOPYRROLIDINE DERIVATIVES | 2006 |
|
RU2420524C2 |
| COMPOSITION FOR COMBATTING IMMUNITY DEFICIENCY VIRUS | 1991 |
|
RU2044544C1 |
| AEROSOL FLUOROCHINOLONES AND THEIR APPLICATIONS | 2006 |
|
RU2428986C2 |
| PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2270695C2 |
| MALIC ACID SALTS AND (3S,5S)-7-[3-AMINO-5-METHYLPIPERIDINYL]-1-CYCLOPROPYL-1,4-DIHYDRO-8-METHOXY-4-OXO-3-CHINOLINE CARBOXYLIC ACID POLYMORPHS | 2007 |
|
RU2417222C2 |
